Amicus Therapeutics

POMBILITI

Manufacturer:

Amicus Therapeutics

Pombiliti HCPCS:

J1203

HCPCS Code Descriptor:

Injection, cipaglucosidase alfa-atga, 5 mg

Category:

J Code

Pombiliti NDCs:

71904-0200-01

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Pombiliti:

POMBILITI is aligned to the J Code: J1203. POMBILITI is a Genetic Disorder product produced by Amicus Therapeutics and administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1203 Added Date:

4/1/24

J1203 Effective Date:

4/1/24

J1203 Deactive Date:

HCPCS Active

We have not yet identified a manufacturer source of billing and coding information for Pombiliti
Pombiliti patient assistance information can be found through Amicus Therapeutics at the URL: https://www.amicusassist.com/
POMBILITI prescribing information can be found at the link below:
Information regarding POMBILITI’s potential side effects can be found at MedlinePlus